chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st Hep B vaccination on 6/2/14. No adverse event. 2nd Hep B vaccination on 7/28/14. Within one week, experienced swelling of left knee and severe joint pain. The pain and swelling got progressively worse throughout the next few months. I received the 3rd and final Hep B shot of the series in October. Within a few days of this final shot, swelling spread to my elbow and I experienced severe neck, shoulder, and hip pain. Ankle and toes on left side also swelled. These symptoms continued to get worse until I was seen by a rheumatologist. I received a steroid injection in my knee in October which relieved the knee swelling and pain for about two weeks before returning. The rheumatologist I saw in January gave me another steroid injection in the knee and put me on 20mg of oral methotrexate weekly. Also on 500mg of naproxen twice a day or as needed (usually once a day). With this treatment swelling has subsided but I still experience knee pain and can not participate in high impact activities like jogging or any kind of jumping. Rheumatologist has tentatively diagnosed me with undifferentiated arthritis as it is not following classic bilateral pattern normally seen with RA and instead presenting in asymmetrical fashion. I am getting a master's degree in genetic counseling and am no way anti-vaccination, but I largely believe that I have some genetic vulnerability which made me more sensitive to the effects of the HepB vaccination.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 13-JUN-2016, the patient was vaccinated with improperly stored VARIVAX lot # L043622, expiry date 03-NOV-2017 (dose, route and site of administration were not reported). No adverse effects were reported. Administered vaccine experienced the temperature excursion of 8.2 degrees Fahrenheit for 22 hours. Data logger was involved. The previous excursions were as follows: on 14-MAY-2016 6 degrees Fahrenheit for 1.5 hours, on 20-MAY-2016 5.9 degrees Fahrenheit for 5.5 hours, on 08-JUN-2016, 6.9 degrees Fahrenheit for 3 hours, 50 minutes, on 09-JUN-2016 8.2 degrees Fahrenheit for 9 hours, 50 minutes, on 10-JUN-2016 6.6 degrees Fahrenheit for 1 hour, 50 minutes. The freezer returned to proper range in between all excursions. This is one of several reports received from the same source. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of hives in a male patient who received SHINGRIX (batch number H547E, expiry date 22nd February 2021) for prophylaxis. On 13th September 2018, the patient received the 2nd dose of SHINGRIX .5 ml. In September 2018, 3 days after receiving SHINGRIX, the patient experienced hives. The patient was treated with steroid cream. On an unknown date, the outcome of the hives was unknown. It was unknown if the reporter considered the hives to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received a dose of SHINGRIX on left arm. About 3 hours after vaccination, the patient experienced hives on legs, trunk and arms. The patient had used topical steroid cream and taken hot bath to treat and the hives went away and then came back.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient received Booster Dose of Moderna after receiving J&J as first dose. Patient fainted in waiting area while seated approximately 10 minutes after the injection. Patient revived on her own and was helped to a sitting postion on the floor. She did not complain of any pain or injury and fully recovered and was escorted home by her husband.
Two days following vaccine administration, the patient developed a rash around the injection site of the right thigh where the Prevnar 13 was given. The rash spread along the right lower back and around the right side of the abdomen. The rash resolved and faded after a couple of days and with no other issues except for a low grade fever on the day the rash appeared. Fever resolved and so did the rash.
I got the first shot on 1/22/21.  This was exactly one week ago.  This morning my arm has a large rash and has been a bit itchy.  I also do not feel the greatest today.
Upon next day, just over 24 hours following immunization, patient reported significant swelling at site of administration. She described it as "size of a golf ball" at the site that radiates down her arm to the crook of her elbow.
About four weeks after the second dose of the vaccine I got a rash under my right arm that went toward my elbow and and extended front and back. It lasted about a week and then it scabbed over and cleared up. Now I still have a stinging and numbing sensation in the same place where the rash was. It is concentrated where the ends of the rash was. I was diagnosed with Shingles and given some antiviral medication for one week. It has been three weeks and I still have some pain and tingling. I have not had the Shingles vaccine.
This case was reported by a lawyer and described the occurrence of vaccine-related injuries in a 4-year-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  On 26 August 2005, the subject received unspecified dose of PEDIARIX (unknown).  At an unspecified time after vaccination with PEDIARIX, the subject experienced vaccine-related injuries.  At the time of reporting the outcome of the events was unspecified.
ADULT OBSTRUCTIVE SLEEP APNEA, MILD 11/23/2022 MOOD DISORDER PHYSIO COND W/DEPRESSIVE FEATURE
12/12 slight fever. 12/14 fever-102. 12/15 approx 20sec seizure,  screaming insued, exp another short seizure, then another lasting 20 minutes, turned blue, lost consciousness, foamed at mouth. At ER-unable to follow voice. Rash-12/16.
Headache, nausea, chills, fever, body/joints ache, fatigue, swollen lymph gland under left arm.  4:30 am 2/3/2021 to 2:00 pm 2/4/2021
The day after I felt achy and fatigued, on the 21st I woke up at night sweating with tachycardia about 120-130 beats per minute, went to doctor on 22nd and confirmed tachycardia, thyroid, anemia, and all other labs came back normal, no irregular heart beat with EKG and normal chest x-ray, continued tachycardia at night through the 26th, and continued rapid heart rate off and on during the day to the present November 5th. Went to ER on 30th due to dizziness then both arms went numb and could not move them.
Patient had a little bit of swelling Wednesday night. Thursday experiencing increased pain. Friday very painful and red.
The body aches started in his shoulder and now are all over his neck, back and whole body aches; The body aches started in his shoulder and now are all over his neck, back and whole body aches/ feeling like he has 1,000 pounds on his back; The body aches started in his shoulder and now are all over his neck, back and whole body aches; Body aches/The body aches started in his shoulder and now are all over his neck, back and whole body aches; Headache; Chills; Feel like crap; Low grade temperature; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old male patient received BNT162B2 (Pfizer-BioNTech Covid-19 vaccine, lot number EL0142) intramuscularly at right shoulder approximately at 17:30 on 29Dec2020 for Covid-19 immunization. The patient's medical history included diagnosed allergies, compromised immune status, respiratory illness, genetic / chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity (a little over weight but he is fit). The patient had COVID in the end of Apr2020. The patient had no family medical history and had no prior vaccinations within four weeks. The patient had no concomitant medication. The second day of the vaccination, the patient called to report body aches, headache, chills, low grade temperature. As he reported, he just woke up and was walking around feeling like he had 1000 pounds on his back and felt like crap. The body aches started in his shoulder and currently all over his neck, back and whole body aches. Chills started last night (vaccination night). He was just trying to get to sleep and had to put an extra sweatshirt on last night. He did not check his temperature until he got up and it was 99.2 degrees Fahrenheit. He was not able to provide a start date for the temperature. "Body aches, headache between, chills between, low grade temperature (unspecified start date), feels like crap" were considered developing between 24:00-01:00. He stated that they were all medically significant and he needs a day to recover hopefully. He just felt like he was hit by a truck. The patient had not visited physician or went to ER yet. The outcome of low grade temperature was unknown, chills was resolving and all other events did not resolve at the time of reporting.; Sender's Comments: There is a reasonable possibility that the events vaccination site pain, headache, chills, and pyrexia were related to BNT162b2 based on known drug safety profile. The association between the other reported events with BNT162b2 can not be completely excluded based on temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
t101 given APAP-temp came down; devel hives @ arm pits, legs, abd, chest; seen by MD who ordered meds;
This spontaneous report as received from a physician via a company representative refers to male patient, currently 83 year old. The patient's medical history, drug reactions/allergies and concomitant medications were not reported. On 07-MAR-2018 the patient was vaccinated with PNEUMOVAX 23 (dose, frequency, route, lot # and expiry date were not reported) for vaccination. Shortly after administration of the PNEUMOVAX 23, the patient experienced respiratory issues, fainted and also had slow heart rate, on 07-MAR-2018. The outcome of syncope, heart rate decreased and respiratory disorder was reported as recovered/resolved on 07-MAR-2018 (reported as symptoms resolved after about one hour). The relationship between the events and PNEUMOVAX 23 was not provided. No product quality complaint involved.
pt recv vax 22JAN97 & pt became pregnant;LMP was 13DEC96;OCT97 pt delivered an infant w/poss omphalocele or gastroschisis;
Soreness and swollen at the injection site, stiffness, numbness, and nausea.
EXTREMEM FATIGUE, RED RASH ON BODY (LASTED FOR ABOUT 10 HOURS), NAUSEA, EXTREMEM HEADACHE, CHILLS, SWEATING
Next day 04/01/21  patient hallucinated that there were spiders on the wall, a-fib went crazy, shortness of breath, sweating, vomiting.
Pain at injection site on right arm; slight chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site on right arm) and CHILLS (slight chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Asthma. Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMIN [VITAMINS NOS] and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site on right arm) and CHILLS (slight chills). On 04-Feb-2021, VACCINATION SITE PAIN (Pain at injection site on right arm) and CHILLS (slight chills) had resolved.            Concomitant medications also include Thyroid medicine and Allergy medicine. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Treatment information was  provided.    Reporter did not allow further contact
Information has been received from a pharmacist concerning a 79 year old female patient with penicillin allergy who on unspecified date was vaccinated with a second dose of PNEUMOVAX 23, 0.5 IM (Lot # 663889/0632Y). Concomitant therapy included influenza virus vaccine (unspecified). 12-24 hours after receiving vaccination, the patient experienced paralysis to her arms and legs. On unspecified date, the patient recovered. Patient received the first dose of PNEUMOVAX 23 six years ago. The patient's paralysis of her arms and legs was considered disabling by the pharmacist. Additional information has been requested.
Pt stated with itchy hives all over face when leaving clinic on 1/7/2021.  Pt has hx of allergies, so took Benedryl when arriving to home.  Pt also has Epi-pen but did not need to use medication.    Hives subsided to look like smaller splotchy patches on face only.  Condition continues to improve but has not subsided completely as of 1/8/2020 3:52 pm.   No other sx per pt.
developed pain in the left side of cheek, feels as if someone has slapped in the face. there is mild numbness as well. eating/talking or touching my face reproduces the pain.; developed pain in the left side of cheek, feels as if someone has slapped in the face. there is mild numbness as well. eating/talking or touching my face reproduces the pain.; This is a spontaneous report from a contactable physician reported for herself. A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 26Jan2021 12:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history was none. Patient was not pregnant. The patient's concomitant medications were not reported.  On 30Jan2021 at 19:00, patient developed pain in the left side of cheek, it felt as if someone had slapped her in the face. There was mild numbness as well. It got worse towards the end of the night. Eating/talking or touching face reproduced the pain. Patient had not been ill or taken any medications since the vaccine and was in good health. No prior symptoms such as this. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment for the events was reported as unknown. Outcome of the events was not resolved. This case was reported as non-serious.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
My blood pressure dropped down to 93 over 48; I lost almost 45 Lbs; I was terrible sick because of your vaccine; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced a very sever reaction to it, patient spent the better part of 2 weeks not even knowing what day it was, patient lost almost 45 lbs and was almost put in the hospital because blood pressure dropped down to 93 over 48 and patient was terribly sick because of vaccine. Patient wished to god o would have never taken this vaccine. it almost killed patient and a month later patient was just now coming out of it. The outcome of events was unknown.  Information on the lot/batch number has been requested.
This is a cluster of 4 cases linked with AER 2012-09425, 2012-09427 and 2012-09434 developed adverse events following the FLUZONE ID administration (lot number UT4467AA). This case is also linked with 2012-09426, 2012-09424, 2012-09431. Initial and follow up report received from a healthcare professional on 05 October 2012. A 43-year-old female patient, whose medical history and concomitant medications were not reported, had received a dose of FLUZONE intradermal (lot number UT4467AA) in the left/right deltoid on 18 September 2012 or 19 September 2012 or 25 September 2012 or 28 September 2012. Within about 24 hours of vaccination, arm had 3 inch round welt and swelling and redness from side to side of shoulder and markedly raised and also have considerable itching. Lab investigations and corrective treatments were not reported. The patient's outcome was recovered on unspecified date. Documents held by sender: None.
I'm experiencing severe pain in the chest that doesn't go away, very strong, not normal; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient reported for herself). A 25-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ew0151), dose 2 via an unspecified route of administration, administered in left arm on 07Apr2021 at 14:00 (at the age of 25-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. No known allergies were reported. Concomitant medications included camellia sinensis, levocarnitine, taurine (FAT BURNER L CARNITINA COMPLEX) taken for an unspecified indication, start and stop date were not reported. Historical vaccine given to patient previously was bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ew0179), dose 1 via an unspecified route of administration, administered in left arm on 28Apr2021 at 12:30 (at the age of 25-year-old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other vaccines on the same date the COVID vaccine was administered. Other medications the patient received within 2 weeks of vaccination included fat burner. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 29Apr2021 at 16:00, the patient experienced severe pain in the chest that did not went away, very strong, not normal. The event had not resulted in for death, life-threatening, prolonged hospitalisation, disabling/incapacitating or Congenital anomaly/birth defect. No treatment was received for the event. The outcome of the event was reported as not resolved.  No follow-up attempts are needed. No further information is expected.
5 days after receiving DTaP, HIB, IPV, and Prevnar developed seizures. Admitted to hospital on 03/15/2003 for sull sepsis work up (neg), MRI of head/EEG led to follow up by pediatric neurologist as requested. The hospital discharge summary received on 1/8/04 states paroxysmal dystonic arm movements, drooling, right caudate subacute hemorrhage, cough, and sneezing. Patient still having complex partial seizures.
Information has been received from a medical assistant concerning an unspecified number of patients of unknown ages and gender. The patient's pertinent medical history, relevant laboratory data and concurrent conditions were not informed. On 17-OCT-2016 the patients were vaccinated with incorrect storage VAQTA lot # M018644, expiration date 20-SEP-2017, 5 ml administered per intramuscular route. Concomitant therapies were not informed. The medical assistant reported that on unspecified dates, the VAQTA had undergone a temperature excursion. It was informed that at the time of the report, the patients had not experienced any adverse reaction and had not been provided any treatment. It was unknown if the patients continue to receive VAQTA. This is one of several reports received from the same reporter. Additional information has been requested.
Patient had injection site pain/arm pain. Progressed to difficulty lifting arm. Did not improve within 48 hours.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 17-SEP-2012 the patient was vaccinated with an expired dose of 0.65 ml ZOSTAVAX (lot # 669260/0152AA; exp. 01-MAY-2012). It was unknown if the patient had sought medical attention. No adverse effects reported. Additional information has been requested.
I95.9 HYPOTENSION 4/28/2023 HYPOTHYROIDISM
This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (The vaccine put her down for a couple days.) and INFLUENZA LIKE ILLNESS (Felt like she had the flu really bad) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939893) for COVID-19 vaccination. No Medical History information was reported. On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced ASTHENIA (The vaccine put her down for a couple days.) and INFLUENZA LIKE ILLNESS (Felt like she had the flu really bad). At the time of the report, ASTHENIA (The vaccine put her down for a couple days.) and INFLUENZA LIKE ILLNESS (Felt like she had the flu really bad) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medication information provided. No relevant treatment medication information provided. Patient reported that she received her 2nd dose of Moderna vaccine on her left arm on 07-Sep-2021. LOT # 017E21A; This case was linked to MOD-2021-312953 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded. Therefore, causality is assessed as possibly related.
92y.o. female with multiple medical problems including hypertension, hypothyroidism, chronic constipation, and CKD admitted on 8/28/22 for metabolic encephalopathy related to severe hyponatremia (Na 106). Workup revealed tea and toast syndrome with SIADH component. Per her son, patient initially tested positive for COVID ~2 weeks ago and was COVID+ at hospital on admission. ID consulted with no specific COVID tx recommended. CXR on 9/1 shows bibasilar and perihilar airspace disease, she continues to have dry cough. Patient required MICU stay 8/27-8//31 with improvement of symptoms.  Sodium has improved with oral fluid restriction of 1000cc and 1 g salt tablets (9/2-present). Urine studies suggestive of SIADH, likely component from COVID. The patient will be discharged with son in a 1SH with 1 stairs to enter.  The patient has a fair prognosis for returning to this environment.
pt rcvd vax; pt had seizure disorder; phenobarbitol treatment ongoing;
Patient should not have received this vaccine due to his age- less than 18 at the time of administration.